0000000000462107

AUTHOR

Dipali Rathod

showing 4 related works from this author

Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi‐center study

2020

Frontal fibrosing alopecia (FFA) mainly affects the anterior hairline and eyebrows and its etiology and associated factors remain obscure. The aim of this study was to evaluate the allergic contact dermatitis with patch test in patients with FFA. In this prospective study, 20 patients with FFA and 24 age and sex-matched healthy individuals were evaluated with patch testing. Diagnosis was made histologically, clinically and based on dermoscopic findings. Demographic data, age of onset, disease duration and FFA severity index are evaluated in all patients. Positive patch test reaction to one or more allergen was observed in 65% of patients while it was 37.5% in control group (P = .003). There…

medicine.medical_specialtyDermatologymedicine.disease_cause030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAllergenQuality of lifemedicineHumansProspective StudiesProspective cohort studyAllergic contact dermatitisbusiness.industryFrontal fibrosing alopeciaLichen PlanusPatch testAlopeciaGeneral Medicinemedicine.diseaseDermatology030220 oncology & carcinogenesisDermatitis Allergic ContactQuality of LifeEtiologyAge of onsetbusinessDermatologic Therapy
researchProduct

Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum

2019

Introduction: Pyoderma gangrenosum (PG) is a noninfectious, reactive inflammatory neutrophilic dermatosis that is commonly associated with autoimmune and neoplastic disorders. There are emerging diagnostic tools and treatment options for PG.Area covered: The diagnosis of PG should be seriously considered when managing ulcers to avoid unnecessary medical and surgical complications with prompt and suitable treatment. There are no standardized treatment guidelines for PG, and current therapy largely depends on the severity and progression of the disease. Systemic corticosteroids, immunosuppressant therapy, and biologic agents remain mainstay therapies. In this article, we present a literature …

medicine.medical_specialtyDiseaseDiagnostic toolsSeverity of Illness Index030226 pharmacology & pharmacySystemic therapyBiological Factors03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesmedicineHumansPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsIntensive care medicineClinical treatmentbusiness.industryGeneral MedicineGold standard (test)medicine.diseasePyoderma GangrenosumBiologic AgentsNeutrophilic dermatosis030220 oncology & carcinogenesisDisease ProgressionDermatologic AgentsbusinessImmunosuppressive AgentsPyoderma gangrenosumExpert Review of Clinical Pharmacology
researchProduct

Postherpetic neuralgia and recalcitrant cystic lesions following herpes zoster: A case report and review of treatment options.

2020

Acute herpes zoster lesions in most cases are self-limited except in older and immunocompromised patients, wherein the pain can cause significant suffering. Postherpetic neuralgia is a painful situation for patients that can compromise the quality of life. Here, we report a 30-year-old healthy young man who developed treatment-resistant postherpetic neuralgia after herpes zoster (fourth/fifth thoracic segment) without any underlying immunocompromised state. He also developed some cystic lesions, which were removed by aspiration and surgery. The skin lesions improved 2 weeks after the surgery and postherpetic neuralgia was completely cured after 5 months, however cystic lesions recurred mult…

AdultMalemedicine.medical_specialtyNeuralgia PostherpeticDermatologyHerpes Zoster030207 dermatology & venereal diseases03 medical and health sciencesCystic lesion0302 clinical medicineRecurrencemedicineHumansTreatment resistantAgedPostherpetic neuralgiabusiness.industryTreatment optionsGeneral Medicinemedicine.diseaseDermatologynervous system diseasesbody regions030220 oncology & carcinogenesisQuality of LifeSkin lesionbusinessDermatologic therapyREFERENCES
researchProduct

A cross‐sectional, multi‐center study on treatment of facial acne scars with low‐energy double‐pass 1450‐nm diode laser

2020

Acne scars are the ultimate outcome of acne vulgaris, a prevalent skin disorder affecting the pilo-sebaceous unit. Laser resurfacing has been demonstrated to be an efficient therapy option for acne scars. Hence, we adopted this concept and conducted a study to evaluate the safety and efficacy of low-energy double-pass 1450-nm diode laser on acne scars. This study was conducted on 48 patients with acne scars, treated at 4-week interval with low-energy double-pass 1450-nm diode laser. Patients were evaluated clinically and with photographs, at day 0, first month and third month post the final treatment and during follow-up visit. Five treatment sessions were completed by all patients. Approxi…

medicine.medical_specialtyDermatologyDouble passlaw.inventionCicatrix030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineLow energylawAcne VulgarisHumansMedicineAcne scarsAcnebusiness.industryLaser treatmentGeneral MedicineLasermedicine.diseaseHyperpigmentationDermatologyCross-Sectional StudiesTreatment Outcome030220 oncology & carcinogenesisMulti center studyLaser TherapyLasers Semiconductormedicine.symptombusinessDermatologic Therapy
researchProduct